scholarly journals Renal accumulation and clearance of advanced glycation end-products in type 2 diabetic nephropathy: effect of angiotensin-converting enzyme and vasopeptidase inhibition

Diabetologia ◽  
2005 ◽  
Vol 48 (8) ◽  
pp. 1645-1653 ◽  
Author(s):  
C. Wihler ◽  
S. Schäfer ◽  
K. Schmid ◽  
E. K. Deemer ◽  
G. Münch ◽  
...  
Keyword(s):  
Diabetic Nephropathy ◽  
Angiotensin Converting Enzyme ◽  
Advanced Glycation End Products ◽  
Converting Enzyme ◽  
Advanced Glycation ◽  
Vasopeptidase Inhibition ◽  
Glycation End Products ◽  
End Products ◽  
Type 2 Diabetic

Effect of pyridoxamine (K-163), an inhibitor of advanced glycation end products, on type 2 diabetic nephropathy in KK-Ay/Ta mice

Metabolism ◽  
2007 ◽  
Vol 56 (2) ◽  
pp. 160-167 ◽  
Author(s):  
Mitsuo Tanimoto ◽  
Tomohito Gohda ◽  
Shigeru Kaneko ◽  
Shinji Hagiwara ◽  
Maki Murakoshi ◽  
...  
Keyword(s):  
Diabetic Nephropathy ◽  
Advanced Glycation End Products ◽  
Advanced Glycation ◽  
Glycation End Products ◽  
End Products ◽  
Type 2 Diabetic

scholarly journals Blockage of receptor for advanced glycation end products prevents development of cardiac dysfunction in db/db type 2 diabetic mice

2009 ◽  
Vol 11 (7) ◽  
pp. 638-647 ◽  
Author(s):  
Jan M. Nielsen ◽  
Steen B. Kristiansen ◽  
Rikke Nørregaard ◽  
Claus L. Andersen ◽  
Larry Denner ◽  
...  
Keyword(s):  
Advanced Glycation End Products ◽  
Cardiac Dysfunction ◽  
Diabetic Mice ◽  
Advanced Glycation ◽  
Glycation End Products ◽  
End Products ◽  
Type 2 Diabetic
Sign in / Sign up

Export Citation Format

Share Document